31 agosto 2015
Patients with type-2 diabetes and cardiovascular disease can safely take the antihyperglycemic drug sitagliptin without an increased risk of cardiovascular complications – even if they have a history of heart failure – a new analysis shows.
http://www.sciencedaily.com/releases/2015/08/150831085502.htm
